全文获取类型
收费全文 | 2784951篇 |
免费 | 205400篇 |
国内免费 | 4295篇 |
专业分类
耳鼻咽喉 | 38169篇 |
儿科学 | 90745篇 |
妇产科学 | 74207篇 |
基础医学 | 412726篇 |
口腔科学 | 77358篇 |
临床医学 | 251872篇 |
内科学 | 538670篇 |
皮肤病学 | 61927篇 |
神经病学 | 217123篇 |
特种医学 | 103989篇 |
外国民族医学 | 553篇 |
外科学 | 418147篇 |
综合类 | 58188篇 |
现状与发展 | 12篇 |
一般理论 | 964篇 |
预防医学 | 216196篇 |
眼科学 | 65353篇 |
药学 | 208636篇 |
13篇 | |
中国医学 | 6267篇 |
肿瘤学 | 153531篇 |
出版年
2021年 | 22497篇 |
2019年 | 22884篇 |
2018年 | 31597篇 |
2017年 | 23863篇 |
2016年 | 26746篇 |
2015年 | 30116篇 |
2014年 | 42342篇 |
2013年 | 63565篇 |
2012年 | 87091篇 |
2011年 | 92150篇 |
2010年 | 54839篇 |
2009年 | 51823篇 |
2008年 | 86553篇 |
2007年 | 92213篇 |
2006年 | 93301篇 |
2005年 | 89960篇 |
2004年 | 86346篇 |
2003年 | 82854篇 |
2002年 | 80449篇 |
2001年 | 129512篇 |
2000年 | 132697篇 |
1999年 | 111270篇 |
1998年 | 31877篇 |
1997年 | 27834篇 |
1996年 | 28228篇 |
1995年 | 26733篇 |
1994年 | 24607篇 |
1993年 | 23139篇 |
1992年 | 85999篇 |
1991年 | 83936篇 |
1990年 | 81729篇 |
1989年 | 79120篇 |
1988年 | 72754篇 |
1987年 | 71261篇 |
1986年 | 66892篇 |
1985年 | 63828篇 |
1984年 | 47433篇 |
1983年 | 40282篇 |
1982年 | 23663篇 |
1979年 | 43591篇 |
1978年 | 30966篇 |
1977年 | 25850篇 |
1976年 | 24753篇 |
1975年 | 26633篇 |
1974年 | 31876篇 |
1973年 | 30434篇 |
1972年 | 28517篇 |
1971年 | 26932篇 |
1970年 | 25101篇 |
1969年 | 23735篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Tissue-specific regulation of pyroglutamate aminopeptidase II activity by thyroid hormones 总被引:2,自引:0,他引:2
Among the enzymes capable of degrading thyrotropin-releasing hormone (TRH) in vitro, two pyroglutamate aminopeptidases (PGA) are specific for TRH: thyroliberinase, a seric enzyme and PGAII, a membrane-bound peptidase. The effect of thyroid hormone status on the activity of these enzymes was evaluated in serum and various tissues. Only in adenohypophysis, triiodothyronine treatment increased PGAII to 376% of control; hypothyroidism produced the reverse effect (decrease to 23% of control). As previously reported, similar changes were observed for thyroliberinase. TRH degradation at the adenohypophysis level may participate in the negative feedback control of thyroid hormones. 相似文献
992.
A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry 总被引:2,自引:0,他引:2
A M Haines S E Larkin A P Richardson R W Stirling E Heyderman 《British journal of cancer》1989,60(6):887-892
A murine monoclonal antibody PASE/4LJ to prostatic acid phosphatase (PAP) was used to immunostain a wide variety of sections of benign and malignant tissues (654 blocks). Non-neoplastic adult and fetal prostatic glands, primary and metastatic prostatic carcinomas, and scattered cells in prostatic and penile urethra were positive. Rat, dog and rabbit prostates were negative. Nine of 400 tumours of non-prostatic origin showed some positivity: 6/36 carcinoids, 1/9 islet cell tumours, 1/55 ovarian adenocarcinomas (serous) and one carcinosarcoma of the lung (epithelial portion). Positive staining was seen in islet cells in 4/5 specimens of normal pancreas, and in 4/9 blocks of normal pancreas surrounding a pancreatic tumour. Loops of Henle, maculae densae, and distal tubules in 10/10 fetal and 2/9 adult kidneys were also positive, with proximal tubules and collecting ducts negative. All other 159 blocks of non-neoplastic adult and fetal tissues were negative. The antibody was also affinity purified from ascitic fluid, and shown not to inhibit the enzyme activity of prostatic acid phosphatase. 相似文献
993.
Summary. In this study, we have examined our records for the isolation of Candida tropicalis from clinical specimens of patients with heterogeneous clinical presentations during the past 5 years. We have found that this species ranks third among all yeasts in frequency of isolation from clinical specimens and that the trend of recovery from the specimens is rising over the years. The isolation rate of C. tropicalis was highest from urine specimens (36%) followed by respiratory specimens (22%). The frequency of isolation of C. tropicalis from vaginal specimens was relatively high (14%), however the trend was declining over the years. In general, the high recovery of Candida tropicalis from clinical specimens of patients with variable disease supports the views of this organism being a major pathogen.
Zusammenfassung. Die Studie basiert auf einer Durchsicht der Patientenarchive der letzten fünf Jahre auf die Isolationshäufigkeit von Candida tropicalis aus klinischen Untersuchungsmaterialien von Patienten mit unterschiedlichen klinischen Krankheitsbildern. Diese Hefeart war die dritthäufigste mit steigender Tendenz über die Jahre. Die Isolierungsrate von C. tropicalis war am höchsten aus Urin (36%), gefolgt von Respirationstrakt-Materialien (22%). Die Isolationshäufigkeit aus dem hinteren Scheidengewölbe war relativ hoch (14%), nahm jedoch mit den jahren ab. Allgemein unterstreicht die hohe Isolationsrate von C. tropicalis aus klinischen Untersuchungsmaterialien die ätiologische Bedeutung dieses Erregers. 相似文献
Zusammenfassung. Die Studie basiert auf einer Durchsicht der Patientenarchive der letzten fünf Jahre auf die Isolationshäufigkeit von Candida tropicalis aus klinischen Untersuchungsmaterialien von Patienten mit unterschiedlichen klinischen Krankheitsbildern. Diese Hefeart war die dritthäufigste mit steigender Tendenz über die Jahre. Die Isolierungsrate von C. tropicalis war am höchsten aus Urin (36%), gefolgt von Respirationstrakt-Materialien (22%). Die Isolationshäufigkeit aus dem hinteren Scheidengewölbe war relativ hoch (14%), nahm jedoch mit den jahren ab. Allgemein unterstreicht die hohe Isolationsrate von C. tropicalis aus klinischen Untersuchungsmaterialien die ätiologische Bedeutung dieses Erregers. 相似文献
994.
995.
996.
There has been a remarkable change in the scenario of therapeutic apheresis in the last 14 years in India. The crude method of manual removal of blood followed by separation of plasma by gravity, keeping it in the bottle for a long time, has now been totally replaced by plasmapheresis, centrifugation, membrane filtration, and immunoadsorption techniques. The indications for use have also changed from a list of limited indications in the beginning to include all immune complex disorders. The clinical beneficiaries have also increased from blood bankers to nephrologists and immunologists in addition to oncologists. Efforts are now underway with the help of the Indian Society for Apheresis (founded in 1985) to popularize the newer methods of cryofiltration, photopheresis and heparin extracorporeal low-density lipoprotein (HELP) and DALI apheresis systems besides the specialized techniques of immunoadsorption using filters, columns, or ligands. This is suggestive of a positive trend for the treatment of immune complex disorders. 相似文献
997.
998.
999.
1000.